Pediatric Ontogeny: Ready for Incorporation into Modeling in Pediatric Drug Development?

The Food and Drug Administration (FDA or the Agency) is announcing a public workshop to discuss the present state of understanding of pediatric ontogeny as it pertains to pediatric drug development. The workshop aims to address the incomplete information available on the ontogeny of several relevant

Source: FDA Center for Drug Evaluation and Research - What's New - June 27, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news